20 results on '"Vaňousová D."'
Search Results
2. Identification of Anaplasma phagocytophilum and Borrelia burgdorferi sensu lato in patients with erythema migrans
- Author
-
Hulínská, D., Votýpka, J., Vaňousová, D., Hercogová, J., Hulínský, V., Dřevová, H., Kurzová, Z., and Uherková, L.
- Published
- 2009
- Full Text
- View/download PDF
3. P08.14 Lymphogranuloma venereumin the czech republic
- Author
-
Klepetková, H, primary, Machala, L, additional, Rob, F, additional, Vaňousová, D, additional, and Zákoucká, H, additional
- Published
- 2015
- Full Text
- View/download PDF
4. DNA persistence after treatment of Lyme borreliosis
- Author
-
Pícha, D., primary, Moravcová, L., additional, Vaňousová, D., additional, Hercogová, J., additional, and Blechová, Z., additional
- Published
- 2013
- Full Text
- View/download PDF
5. Steady increase of lymphogranuloma venereum cases, Czech Republic, 2010 to 2015.
- Author
-
Rob, F., Jůzlová, K., Krutáková, H., Zákoucká, H., Vaňousová, D., Kružicová, Z., Machala, L., Veselý, D., Jilich, D., and Hercogová, J.
- Published
- 2016
- Full Text
- View/download PDF
6. Condylomata acuminata (genitální bradavice).
- Author
-
Rob, F., Kružicová, Z., Vaňousová, D., and Hercogová, J.
- Published
- 2014
7. Předpokládaná účinnost HPV vakcinace v profylaxi nongenitálních karcinomů.
- Author
-
Sehnal B., Vojáčková N., Driák D., Kmoničková E., Vaňousová D., Maxová K., Neumannová H., and Slamá J.
- Published
- 2014
8. Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers | Předpokladaná účinnost HPV vakcinace v profylaxi nongenitálních karcinomů
- Author
-
Sehnal, B., Vojáčková, N., Daniel Driák, Kmoníčková, E., Vaňousová, D., Maxová, K., Neumannová, H., and Sláma, J.
9. PCR-detection rates of T. pallidum ssp. pallidum in swab samples from the Czech Republic (2004-2022): Combined RPR, IgM, and PCR tests efficiently detect active syphilis.
- Author
-
Vrbová E, Pospíšilová P, Dastychová E, Kojanová M, Kreidlová M, Vaňousová D, Rob F, Procházka P, Krchňáková A, Vašků V, Strnadel R, Faustmannová O, Heroldová MD, Kuklová I, Zákoucká H, and Šmajs D
- Abstract
Syphilis is a multistage sexually transmitted disease caused by Treponema pallidum ssp. pallidum (TPA). This study analyzed clinical samples collected from patients with a diagnosed syphilis infection from 2004-2022, isolated in the Czech Republic. Mucocutaneous swab samples (n = 543) from 543 patients were analyzed, and from these samples, 80.11 % (n = 435) were PCR positive, and 19.89 % (n = 108) were PCR negative for TPA DNA. Swabs were more often positive when collected from syphilis patients in the primary and secondary stages, compared to the latent or unknown stage. There was no significant difference in PCR positivity between the primary and secondary stages (p = 0.099). In IgM-positive patients, a statistically significant association with PCR-positivity was found in samples from seropositive (p = 0.033) and serodiscrepant (RPR negative) patients (p = 0.0006). When assessing our laboratory-defined cases of syphilis, the RPR, IgM, and PCR tests were similarly effective (within the range of 80.1-86.1 %). However, parallel testing with these methods was even more effective, i.e., RPR + PCR was 96.1 % effective and RPR + IgM + PCR was 97.8 % effective. A combination of RPR + PCR, or a combination of all three tests (RPR, IgM, and PCR) can therefore be used to reliably detect active syphilis cases, including reinfections. Our findings show that the reverse algorithm for detecting syphilis could be substantially improved by adding IgM and PCR testing., (Copyright © 2025 The Authors. Published by Elsevier GmbH.. All rights reserved.)
- Published
- 2025
- Full Text
- View/download PDF
10. A retrospective study on nested PCR detection of syphilis treponemes in clinical samples: PCR detection contributes to the diagnosis of syphilis in patients with seronegative and serodiscrepant results.
- Author
-
Vrbová E, Mikalová L, Grillová L, Pospíšilová P, Strnadel R, Dastychová E, Kojanová M, Kreidlová M, Vaňousová D, Rob F, Procházka P, Krchňáková A, Vašků V, Woznicová V, Dvořáková Heroldová M, Kuklová I, Zákoucká H, and Šmajs D
- Subjects
- Humans, Retrospective Studies, Syphilis blood, Treponema genetics, Treponema immunology, Treponema physiology, Polymerase Chain Reaction, Syphilis diagnosis, Syphilis Serodiagnosis methods, Treponema isolation & purification
- Abstract
Syphilis, caused by Treponema pallidum ssp. pallidum (TPA), is a persisting global health problem. Although syphilis diagnostics relies mainly on serology, serological tests have some limitations, and it is recommended that the final diagnosis be supported by additional tests. The purpose of this study was to analyze the relationship between serology and PCR in syphilis diagnostics. From the year 2004 to May 2019, a total of 941 samples were taken from 833 patients suspected of having syphilis, in Czech Republic. In all these samples, both nested PCR detection of TPA and serology testing were performed. Of the 941 samples, 126 were seronegative, 651 were seropositive, and 164 were serodiscrepant. Among seronegative samples (n = 126), 11 were PCR-positive (8.7%). Among seropositive samples (n = 651; i.e., samples positive for both non-treponemal and treponemal serology tests), 368 samples were PCR-positive (56.5%). The remaining 164 serodiscrepant samples included RPR negative and treponemal serological test-positive samples (n = 154) and a set of 10 RPR-positive samples negative in treponemal serological tests. While the first group revealed 73 PCR-positive samples (47.4%), the second revealed 5 PCR positive samples (50.0%). PCR detection rates were highest in primary syphilis, with lower rates in the secondary and undetermined syphilis stages. As shown here, the nested PCR can improve diagnostics of syphilis, especially in seronegative patients and in patients with discrepant serology., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2020
- Full Text
- View/download PDF
11. Prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae co-infections among patients with newly diagnosed syphilis: a single-centre, cross-sectional study.
- Author
-
Rob F, Jůzlová K, Kružicová Z, Vaňousová D, Lásiková Š, Sýkorová B, Machala L, Rozsypal H, Veselý D, Zákoucká H, and Hercogová J
- Subjects
- Coinfection, Cross-Sectional Studies, Female, HIV Infections epidemiology, Homosexuality, Male statistics & numerical data, Humans, Male, Prevalence, Chlamydia Infections epidemiology, Chlamydia trachomatis isolation & purification, Gonorrhea epidemiology, Neisseria gonorrhoeae isolation & purification, Syphilis diagnosis
- Abstract
Objectives: The aim of the study was to determine the prevalence of Chlamydia trachomatis and Neisseria gonorrhoeae co-infections among patients with newly diagnosed syphilis., Methods: In patients with any stage of newly diagnosed syphilis swabs were performed from urethra, rectum, pharynx and cervix according to the gender and type of sexual intercourse. From these smears standard validated nucleic acid amplification tests (NAATs) for Chlamydia trachomatis and Neisseria gonorrhoeae infections were done., Results: From 548 (488 men, 60 women) screened patients co-infection was detected in 15.9% of the cases. The majority of the co-infections (86.2%) were asymptomatic. The overall prevalence of chlamydial infection was 11.1% and 8.8% for gonococcal infections. In men who have sex with men (MSM) the prevalence of co-infections was significantly higher (20.0%) than in heterosexual men and women (4.2%) (p < 0.001). In MSM patients the presence of co-infection was significantly associated with HIV infection (p < 0.001). Among MSM 9.6% of the tests detected infection in anorectal site, while prevalence in urethral (2.8%) and pharyngeal (2.4%) localization was significantly lower. In heterosexual patients prevalence was less than 2.0% in all anatomic sites., Conclusions: The implementation of screening tests in case of sexually transmitted infections in patients with newly diagnosed syphilis is an important part in the management of this disease. These results suggest that screening of asymptomatic heterosexual patients leads to detection of minimum co-infections, but in MSM (especially HIV positive) should always be performed at least in anorectal site, where asymptomatic co-infections are common.
- Published
- 2019
- Full Text
- View/download PDF
12. MLST typing of Treponema pallidum subsp. pallidum in the Czech Republic during 2004-2017: Clinical isolates belonged to 25 allelic profiles and harbored 8 novel allelic variants.
- Author
-
Vrbová E, Grillová L, Mikalová L, Pospíšilová P, Strnadel R, Dastychová E, Kojanová M, Kreidlová M, Vaňousová D, Rob F, Procházka P, Krchňáková A, Vašků V, Woznicová V, Dvořáková Heroldová M, Kuklová I, Zákoucká H, and Šmajs D
- Subjects
- Adult, Alleles, Anti-Bacterial Agents pharmacology, Czech Republic epidemiology, DNA, Bacterial genetics, Drug Resistance, Bacterial genetics, Female, Genotype, Humans, Male, RNA, Ribosomal, 23S genetics, Syphilis genetics, Syphilis pathology, Treponema pallidum pathogenicity, Young Adult, Multilocus Sequence Typing, Syphilis microbiology, Treponema pallidum genetics
- Abstract
A recently introduced Multilocus Sequence Typing scheme for Treponema pallidum subsp. pallidum was applied to clinical samples collected from 2004 to 2017 from the two largest cities (Prague and Brno) in the Czech Republic. Altogether, a total of 675 samples were tested in this study and 281 of them were found PCR-positive for treponemal DNA and typeable. Most of the typed samples (n = 281) were swabs from primary or secondary syphilis lesions (n = 231), and only a minority were whole blood or tissue samples (n = 50). Swab samples from patients with rapid plasma regain (RPR) values of 1-1024 were more frequently PCR-positive (84.6%) compared to samples from patients with non-reactive RPR test (46.5%; p-value = 0.0001). Out of 281 typeable samples, 136 were fully-typed at all TP0136, TP0548, and TP0705 loci. Among the fully and partially typed samples, 25 different allelic profiles were identified. Altogether, eight novel allelic variants were found among fully (n = 5) and partially (n = 3) typed samples. The distribution of TPA allelic profiles identified in the Czech Republic from 2004 to 2017 revealed a dynamic character with allelic profiles disappearing and emerging over time. While the number of samples with the A2058G mutation was seen to increase (86.7% in 2016/2017), the number of samples harboring the A2059G mutation was found to have decreased over time (3.3% in 2016/2017). In addition, we found several allelic profile associations with macrolide resistance or susceptibility, the gender of patients, as well as patient residence., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
13. Steady increase of lymphogranuloma venereum cases, Czech Republic, 2010 to 2015.
- Author
-
Rob F, Jůzlová K, Krutáková H, Zákoucká H, Vaňousová D, Kružicová Z, Machala L, Veselý D, Jilich D, and Hercogová J
- Subjects
- Adolescent, Adult, Anal Canal microbiology, Chlamydia trachomatis genetics, Czech Republic epidemiology, Humans, Inguinal Canal microbiology, Lymphogranuloma Venereum epidemiology, Lymphogranuloma Venereum microbiology, Lymphogranuloma Venereum pathology, Male, Middle Aged, Polymerase Chain Reaction, Sexually Transmitted Diseases, Bacterial diagnosis, Sexually Transmitted Diseases, Bacterial epidemiology, Sexually Transmitted Diseases, Bacterial microbiology, Young Adult, Chlamydia trachomatis isolation & purification, Coinfection epidemiology, Disease Outbreaks, Homosexuality, Male, Lymphogranuloma Venereum diagnosis, Rectum microbiology
- Abstract
Since the notification of the first case of lymphogranuloma venereum (LGV) in the Czech Republic in 2010, the numbers of LGV cases have steadily increased in the country. In 2015, 40 LGV cases were diagnosed, bringing the total for 2010-2015, to 88 cases. The profile of the most affected group, HIV-positive men who have sex with men with a previous sexually transmitted infection, matches that of those described in LGV outbreaks in western Europe.
- Published
- 2016
- Full Text
- View/download PDF
14. [Condylomata acuminata (genital warts)].
- Author
-
Rob F, Kružicová Z, Vaňousová D, and Hercogová J
- Abstract
Unlabelled: Infection with human papillomavirus is the most common viral sexually transmitted infection that mainly affects younger sexually active population. Genital warts are one of the most common manifestations of this infection. Although not a life-threatening disease, it is difficult to treat and frequent recurrence can traumatize the patient and influence not only his sexual life. Currently there are many treatment possibilities, but none is 100% efficient. Because of the wide range of character manifestation and their different localization is necessary to approach each patient individually. Therefore, there is a major weapon against this disease prevention, a safe sexual behavior and a new vaccination., Keywords: condylomata acuminata, HPV infection, diagnostics, prevention, treatment.
- Published
- 2014
15. Molecular typing of Treponema pallidum in the Czech Republic during 2011 to 2013: increased prevalence of identified genotypes and of isolates with macrolide resistance.
- Author
-
Grillová L, Pĕtrošová H, Mikalová L, Strnadel R, Dastychová E, Kuklová I, Kojanová M, Kreidlová M, Vaňousová D, Hercogová J, Procházka P, Zákoucká H, Krchňáková A, Vašků V, and Šmajs D
- Subjects
- Adult, Czech Republic epidemiology, DNA, Bacterial chemistry, DNA, Bacterial genetics, Female, Genes, Bacterial, Genotype, Humans, Male, Prevalence, RNA, Ribosomal, 23S genetics, Syphilis epidemiology, Treponema pallidum drug effects, Treponema pallidum genetics, Anti-Bacterial Agents pharmacology, Drug Resistance, Bacterial, Genetic Variation, Macrolides pharmacology, Molecular Typing, Syphilis microbiology, Treponema pallidum classification
- Abstract
From January 2011 to December 2013, a total of 262 samples, from 188 patients suspected of having syphilis were tested for the presence of treponemal DNA by PCR amplification of five chromosomal loci, including the polA (TP0105), tmpC (TP0319), TP0136, TP0548, and 23S rRNA genes. Altogether, 146 samples from 103 patients were PCR positive for treponemal DNA. A set of 81 samples from 62 PCR-positive patients were typeable, and among them, nine different genotypes were identified. Compared to a previous study in the Czech Republic during 2004 to 2010, the number of genotypes detected among syphilis patients in a particular year increased to six in both 2012 and 2013, although they were not the same six. The proportion of macrolide-resistant clinical isolates in this 3-year study was 66.7%., (Copyright © 2014, American Society for Microbiology. All Rights Reserved.)
- Published
- 2014
- Full Text
- View/download PDF
16. Syphilis-causing strains belong to separate SS14-like or Nichols-like groups as defined by multilocus analysis of 19 Treponema pallidum strains.
- Author
-
Nechvátal L, Pětrošová H, Grillová L, Pospíšilová P, Mikalová L, Strnadel R, Kuklová I, Kojanová M, Kreidlová M, Vaňousová D, Procházka P, Zákoucká H, Krchňáková A, and Smajs D
- Subjects
- Adult, Cluster Analysis, Czech Republic epidemiology, Female, Genotype, Humans, Infant, Newborn, Male, Middle Aged, Molecular Epidemiology, Multilocus Sequence Typing, Syphilis epidemiology, Treponema pallidum isolation & purification, Syphilis microbiology, Treponema pallidum classification, Treponema pallidum genetics
- Abstract
Treponema pallidum strains are closely related at the genome level but cause distinct diseases. Subspecies pallidum (TPA) is the causative agent of syphilis, subspecies pertenue (TPE) causes yaws while subspecies endemicum (TEN) causes bejel (endemic syphilis). Compared to the majority of treponemal genomic regions, several chromosomal loci were found to be more diverse. To assess genetic variability in diverse genomic positions, we have selected (based on published genomic data) and sequenced five variable loci, TP0304, TP0346, TP0488, TP0515 and TP0558, in 19 reference Treponema pallidum strains including all T. pallidum subspecies (TPA, TPE and TEN). Results of this multilocus analysis divided syphilitic isolates into two groups: SS14-like and Nichols-like. The SS14-like group is comprised of SS14, Grady, Mexico A and Philadelphia 1 strains. The Nichols-like group consisted of strains Nichols, Bal 73-1, DAL-1, MN-3, Philadelphia 2, Haiti B and Madras. The TP0558 locus was selected for further studies because it clearly distinguished between the SS14- and Nichols-like groups and because the phylogenetic tree derived from the TP0558 locus showed the same clustering pattern as the tree constructed from whole genome sequences. In addition, TP0558 was shown as the only tested locus that evolved under negative selection within TPA strains. Sequencing of a short fragment (573bp) of the TP0558 locus in a set of 25 clinical isolates from 22 patients collected in the Czech Republic during 2012-2013 revealed that clinical isolates follow the SS14- and Nichols-like distribution., (Copyright © 2014 Elsevier GmbH. All rights reserved.)
- Published
- 2014
- Full Text
- View/download PDF
17. Juvenile generalized pustular psoriasis treated with etanercept.
- Author
-
Fialová J, Vojáčková N, Vaňousová D, and Hercogová J
- Subjects
- Adolescent, Etanercept, Humans, Immunoglobulin G adverse effects, Immunosuppressive Agents adverse effects, Male, Psoriasis diagnosis, Remission Induction, Time Factors, Treatment Outcome, Immunoglobulin G therapeutic use, Immunosuppressive Agents therapeutic use, Psoriasis drug therapy, Receptors, Tumor Necrosis Factor therapeutic use
- Abstract
An 8-year-old boy with general pustular psoriasis (GPP) and iatrogenic secondary Cushing syndrome was treated successfully with etanercept after he had failed on acitretin, methotrexate, and methylprednisolone therapy. GPP is a severe and very rare variant of psoriasis in children often accompanied by life-threatening complications. Retinoids, cyclosporine, methotrexate, or dapsone used in a small number of case series and case reports were effective. Etanercept is a recombinant human tumor necrosis factor-alpha (TNF-alpha) receptor protein fused with Fc portion of IgG1 that binds to TNF-alpha, approved by Food and Drug Administration for the treatment of moderate-to-severe plaque psoriasis in children and teens who have not responded to other psoriasis treatments. In our patient, etanercept demonstrated significant clinical response associated with long-term efficacy without acute exacerbation, excellent tolerability, and good safety profile., (© 2013 Wiley Periodicals, Inc.)
- Published
- 2014
- Full Text
- View/download PDF
18. [Anticipated efficacy of HPV vaccination in prophylaxis against nongenital cancers].
- Author
-
Sehnal B, Vojáčková N, Driák D, Kmoníčková E, Vaňousová D, Maxová K, Neumannová H, and Sláma J
- Subjects
- Anus Neoplasms prevention & control, Anus Neoplasms virology, Breast Neoplasms prevention & control, Breast Neoplasms virology, Czech Republic, Esophageal Neoplasms prevention & control, Esophageal Neoplasms virology, Female, Genital Neoplasms, Female prevention & control, Genital Neoplasms, Female virology, Head and Neck Neoplasms prevention & control, Head and Neck Neoplasms virology, Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18, Humans, Intestinal Neoplasms prevention & control, Intestinal Neoplasms virology, Lung Neoplasms prevention & control, Lung Neoplasms virology, Male, Neoplasms virology, Papillomavirus Infections complications, Papillomavirus Infections virology, Penile Neoplasms prevention & control, Penile Neoplasms virology, Uterine Cervical Neoplasms, Neoplasms prevention & control, Papillomavirus Infections prevention & control, Papillomavirus Vaccines therapeutic use, Vaccination
- Abstract
Background: There is a considerable number of studies on the efficacy HPV (human papillomavirus) vaccination against different cancers but relevant information is scattered in diverse journals. This paper is a review summarizing current knowledge of the potential of HPV vaccination against all HPV related cancers., Aim: HPV infection is probably the most frequent sexually transmitted disease. At least 13 HPV genotypes are classified as carcinogenic or probably carcinogenic in respect to cervical cancer. Almost 100% of cervical cancers are linked to HPV infection. HPV 16 and HPV 18 are the most frequently involved genotypes and account together for approximately 70% of cervical cancer in the world. Persistent high risk HPV infection is responsible for a significant proportion of vulvar, vaginal, anal and penile carcinomas. The virus has also been implicated in oncogenesis of head and neck cancers, including oropharyngeal cancers. HPV infection can play an important role in cancerogenesis of lung, esophagus, breast, and colon and rectum. On the contrary, published results indicate that HPV infection is not associated with prostate oncogenesis. Strong predominance of HPV 16 has been reported for all HPV associated cancer sites. Generally, it is estimated that approximately 5.2% of all cancers are associated with oncogenic HPV infection. Currently, there are two vaccines on the market; quadrivalent Silgard® (Gardasil®) and bivalent CervarixTM. Large trials for both vaccines have shown efficacy against HPV related infection and disease. Efficacy has been very high in HPV naive subjects to vaccine related types. While HPV vaccination is currently approved for the prevention of cervical cancer, it also has the potential in the prevention of all HPV associated malignancies. The Czech republic belongs to countries that cover HPV vaccination of girls at the age of 13- 14 years by general health insurance. Overall impact of this vaccination remains to be evaluated. The new issues of the role of HPV in oncogenesis, as well as the potential effect of HPV vaccination against HPV related nongenital cancers are discussed., Conclusion: Approximately 5.2% of all human cancers are associated with oncogenic human papillomavirus infection. HPV vaccination against the most risky HPV oncotypes may cause a significant reduction of these cancers mainly in the HPV naive population.
- Published
- 2014
- Full Text
- View/download PDF
19. [Lymphogranuloma venereum].
- Author
-
Vaňousová D, Zákoucká H, Marvan J, Jilich D, Vojáčková N, Hercogová J, and Machala L
- Subjects
- Diagnosis, Differential, Humans, Lymphogranuloma Venereum diagnosis, Lymphogranuloma Venereum therapy, Lymphogranuloma Venereum transmission
- Abstract
Lymphogranuloma venereum is a sexually transmitted disease caused by serovars L1-3 of Chlamydia trachomatis. This infection was originally endemic in tropics and transmitted predominantly by heterosexual contact but since the beginning of the century it spreads in industrialized countries mainly among men having sex with men causing them severe proctitis. In the Czech Republic the first case was diagnosed in 2011. Lymphogranuloma venereum can resemble other forms of anorectal disorders inclusive inflammatory bowel diseases and thus it must be included into differential diagnostic considerations. Definitive diagnosis is based on detection of specific serovars of Chlamydia trachomatis by polymerase chain reaction. In patients with lymphogranuloma venereum it is also necessary to exclude other sexually transmitted diseases, particularly syphilis, HIV and also hepatitis C. The therapy of choice is doxycycline administered for three weeks.
- Published
- 2012
20. Pemphigus vulgaris treated with adalimumab: case study.
- Author
-
Vojáčková N, Fialová J, Vaňousová D, and Hercogová J
- Subjects
- Adalimumab, Anti-Inflammatory Agents administration & dosage, Antibodies, Monoclonal, Humanized administration & dosage, Drug Therapy, Combination, Female, Glucocorticoids administration & dosage, Glucocorticoids adverse effects, Glucocorticoids therapeutic use, Humans, Immunosuppressive Agents administration & dosage, Immunosuppressive Agents adverse effects, Immunosuppressive Agents therapeutic use, Middle Aged, Pemphigus pathology, Remission Induction methods, Treatment Outcome, Anti-Inflammatory Agents therapeutic use, Antibodies, Monoclonal, Humanized therapeutic use, Pemphigus drug therapy
- Abstract
The study describes the case of a patient with a clinical and histopathological diagnosis of pemphigus vulgaris accompanied by severe side-effects of combined immunosuppressive therapy, who achieved a remission of the disease with adalimumab. Pemphigus vulgaris is a chronic blistering disease of the skin and mucous membranes. Before corticosteroids were introduced, mortality was high. Corticosteroids are currently used as first-line therapy. To reduce the dose of corticosteroids, therapeutic combinations with corticosteroid-sparing immunosuppressive agents are used. The therapy brings a number of complications due to its side effects. To achieve a remission of the disease by treating our patient with combined immunosuppressives, we administered adalimumab and achieved a very good clinical response., (© 2012 Wiley Periodicals, Inc.)
- Published
- 2012
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.